Glutathione S-transferase in bone marrow metastases of disseminated neuroblastoma.
Leukaemia Research Fund Remission Unit, Medical School, Newcastle upon Tyne.
Antisera to each of the three main cytosolic forms of glutathione S-transferase (GST; alpha, mu, and pi) has been used to characterise GST expression by metastatic neuroblastoma in bone marrow trephine biopsies taken from 15 patients at presentation and from five of this group at relapse. There was no correlation between expression of extra-nuclear alpha or mu GST and outcome, and no consistent pattern at relapse. Seven of eight expressing nuclear pi GST at presentation died of resistant disease. Three of five cases with no detectable nuclear pi class GST remain alive and disease free. The results provide no encouragement for further investigation of alpha or mu GST in this disease but larger studies of uniformly treated patients may show whether nuclear pi GST expression at presentation indicates likely relapse.
This article has been cited by other articles:
-
Barnette, P., Scholl, R., Blandford, M., Ballard, L., Tsodikov, A., Magee, J., Williams, S., Robertson, M., Ali-Osman, F., Lemons, R., Keller, C.
(2004). High-Throughput Detection of Glutathione S-Transferase Polymorphic Alleles in a Pediatric Cancer Population. Cancer Epidemiol. Biomarkers Prev.
13: 304-313
[Abstract] [Full Text] -
Rollinson, S., Roddam, P., Kane, E., Roman, E., Cartwright, R., Jack, A., Morgan, G. J.
(2000). Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis
21: 43-47
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
